GS967

CAS No. 1262618-39-2

GS967( GS967 | GS-967 | GS 967 | GS458967 )

Catalog No. M11095 CAS No. 1262618-39-2

GS967 is a novel, potent, and selective inhibitor of cardiac late sodium current(late INa).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 50 In Stock
2MG 29 In Stock
5MG 46 In Stock
10MG 68 In Stock
25MG 154 In Stock
50MG 277 In Stock
100MG 485 In Stock
200MG 703 In Stock
500MG 1088 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GS967
  • Note
    Research use only, not for human use.
  • Brief Description
    GS967 is a novel, potent, and selective inhibitor of cardiac late sodium current(late INa).
  • Description
    GS967 is a novel, potent, and selective inhibitor of cardiac late sodium current(late INa); inhibits ATX-II-induced late I(Na) in ventricular myocytes and isolated hearts with IC(50) values of 0.13 and 0.21 μM, respectively.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    GS967 | GS-967 | GS 967 | GS458967
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Sodium Channel
  • Recptor
    late?INa?,isolated hearts| late?INa?,ventricular myocytes
  • Research Area
    Cardiovascular Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    1262618-39-2
  • Formula Weight
    347.22
  • Molecular Formula
    C14H7F6N3O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    FC(C1=NN=C2C=CC(C3=CC=C(OC(F)(F)F)C=C3)=CN21)(F)F
  • Chemical Name
    6-(4-(trifluoromethoxy)phenyl)-3-(trifluoromethyl)(1,2,4)triazolo(4,3-a)pyridine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Belardinelli L, et al. J Pharmacol Exp Ther. 2013 Jan;344(1):23-32.
molnova catalog
related products
  • BI 01383298

    BI 01383298 is a selective inhibitor of the sodium-citrate co-transporter (SLC13A5).

  • R 56865

    R 56865 is a weak potential-operated channel inhibitor that inhibits the late sodium current in human isolated cardiomyocytes.

  • Ralfinamide mesylate

    Ralfinamide mesylate is an orally available Na+ channel blocker.